SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-14-008857
Filing Date
2014-12-10
Accepted
2014-12-10 18:12:57
Documents
1
Period of Report
2014-12-05

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f3120514donini_soligenix.html 3  
1 OWNERSHIP DOCUMENT f3120514donini_soligenix.xml 3 5305
  Complete submission text file 0001213900-14-008857.txt   6950
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Issuer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 29 EMMONS DRIVE, SUITE C-10 PRINCETON NJ 08540
Business Address
Donini Oreola (Reporting) CIK: 0001627575 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-16929 | Film No.: 141279119